Tensile Strength (MPa) of ABS Polymers at 800 and 1200 rpm. by Shaheer Ahmed Khan (17797647)

Subjects:

Variations of shear strength with curing time and normal stress. by Hao Yu (157186)

Subjects:

Different characterization techniques and their uses. by Shaheer Ahmed Khan (17797647)

Subjects:

SEM Samples of FSW Joints: (i) ABS (800 rpm,10 mm/min) [(a) Cross-sectional View, (b) 250X, (c)1000X} (ii) ABS (1200 rpm,10 mm/min) [(d) Cross-sectional View, (e) 250X, (f)1000X} (... by Shaheer Ahmed Khan (17797647)

Subjects:

Experimental run of FSW on CNC milling machine. by Shaheer Ahmed Khan (17797647)

Subjects:

Effect of PU/WG on shear strength of planar joints. by Hao Yu (157186)

Subjects:

Shear stress-shear displacement curves for different curing time. by Hao Yu (157186)

Subjects:

Maximum Axial Force values of PC Polymers at 800 and 1200 rpm. by Shaheer Ahmed Khan (17797647)

Subjects:

KO of iPLA₂γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) STZ mice show changes in glomerular morphology. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) GECs are more susceptible to injury compared to iPLA₂γ KO GECs. by Andrey V. Cybulsky (4007012)

Subjects:

iPLA₂γ KO mice show increased glomerular autophagy. by Andrey V. Cybulsky (4007012)

Subjects:

Podocyte numbers in control and iPLA₂γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

Subjects:

STZ increases glomerular matrix expansion. by Andrey V. Cybulsky (4007012)

Subjects:

Primary data. by Andrey V. Cybulsky (4007012)

Subjects:

The volume of the right (red) and left (blue) IC are shown as a function of age on a logarithmic scale. by Pingling Kwok (14896191)

The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. by Pingling Kwok (14896191)

Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

“…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”

Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

“…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”

DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”